Gilead Sciences, Inc. (GILD) Income Statement
GILD 2025 at a glance
Fiscal year ended December 31, 2025 · U.S. dollarsGILD revenue and net income
Where GILD's revenue goes
2025Each bar shows an amount and its share of revenue. GILD kept 28.9% of revenue as net income.
GILD profit margins
GILD growth rates
to 2025| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| Revenue | +2.4% | +2.6% | +3.6% | −1.0% |
| Gross profit | +3.1% | +2.4% | +2.9% | −2.1% |
| Operating income | +604.0% | +16.9% | +23.5% | −6.2% |
| Net income | +1,672.9% | +22.8% | +133.3% | −7.3% |
| EPS (diluted) | +76.8% | +3.9% | +2.8% | −4.3% |
1-year change and average annual growth (CAGR) over 3, 5 and 10 fiscal years. "—" when a starting value was zero or negative.
GILD quarterly EPS vs estimates
Gilead beat the analyst EPS estimate in 8 of the last 8 quarters. Next report: October 29, 2026 (estimate $2.16).
GILD income statement
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $29.44B | $28.75B | $27.12B | $27.28B | $27.30B | $24.69B | $22.45B | $22.13B | $26.11B | $30.39B |
| Cost of revenue | $6.23B | $6.25B | $5.80B | $5.66B | $6.60B | $4.57B | $4.67B | $4.85B | $4.37B | $4.26B |
| Gross profit | $23.21B | $22.50B | $27.12B | $21.62B | $20.70B | $20.12B | $17.77B | $17.27B | $21.74B | $26.13B |
| Research & development | $5.80B | $5.91B | $5.72B | $4.98B | $4.60B | $5.04B | $4.05B | $3.92B | $3.73B | $5.10B |
| Sales, general & admin | $5.71B | $6.09B | $6.50B | $5.67B | $5.25B | $5.11B | $4.38B | $4.06B | $3.88B | $3.40B |
| Total operating expenses | $11.51B | $20.84B | $11.81B | $14.29B | $10.79B | $16.05B | $8.44B | $7.98B | $7.61B | $8.50B |
| Operating income | $11.70B | $1.66B | $7.61B | $7.33B | $9.92B | $4.07B | $4.29B | $8.20B | $14.12B | $17.63B |
| Interest income | $349.0M | $281.0M | $376.0M | $106.0M | — | — | $227.0M | $964.0M | $1.19B | $790.0M |
| Interest expense | $1.02B | $977.0M | $944.0M | $935.0M | $1.00B | $984.0M | $995.0M | $1.08B | $1.12B | $964.0M |
| Income before taxes | $9.80B | $690.0M | $6.86B | $5.81B | $8.28B | $1.67B | $5.16B | $7.80B | $13.53B | $17.10B |
| Income taxes | $1.29B | $211.0M | −$1.25B | $1.25B | $2.08B | $1.58B | −$204.0M | $2.34B | $8.88B | $3.61B |
| Net income | $8.51B | $480.0M | $5.67B | $4.59B | $6.22B | $123.0M | $5.39B | $5.46B | $4.63B | $13.50B |
| EBITDA | $13.58B | $4.43B | $7.61B | $8.85B | $11.33B | $4.13B | $7.56B | $10.30B | $15.93B | $19.22B |
| EPS (diluted) | $8.15 | $4.61 | $6.72 | $7.27 | $7.29 | $7.09 | $6.63 | $6.67 | $8.84 | $11.56 |
| Gross margin | 78.8% | 78.3% | 100.0% | 79.3% | 75.8% | 81.5% | 79.2% | 78.1% | 83.3% | 86.0% |
| Operating margin | 39.7% | 5.8% | 28.0% | 26.9% | 36.3% | 16.5% | 19.1% | 37.1% | 54.1% | 58.0% |
| Net margin | 28.9% | 1.7% | 20.9% | 16.8% | 22.8% | 0.5% | 24.0% | 24.7% | 17.7% | 44.4% |
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 | Jun '24 | Mar '24 | Dec '23 | Sep '23 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $7.80B | $6.96B | $7.92B | $7.77B | $7.08B | $6.67B | $7.57B | $7.54B | $6.95B | $6.69B | $7.11B | $7.05B |
| Cost of revenue | $1.58B | $1.45B | $1.62B | $1.57B | $1.50B | $1.54B | $1.58B | $1.57B | $1.54B | $1.55B | $2.09B | $1.56B |
| Gross profit | $6.22B | $5.51B | $6.30B | $6.20B | $5.58B | $5.13B | $5.99B | $5.97B | $5.41B | $5.13B | $5.02B | $5.49B |
| Research & development | $1.76B | $1.37B | $1.58B | $1.35B | $1.49B | $1.38B | $1.64B | $1.40B | $1.35B | $1.52B | $1.41B | $1.46B |
| Sales, general & admin | $1.92B | $1.45B | $1.73B | $1.36B | $1.36B | $1.26B | $1.86B | $1.41B | $1.38B | $1.38B | $1.58B | $1.31B |
| Total operating expenses | $16.62B | $2.93B | $3.31B | $2.87B | $3.11B | $2.89B | $3.54B | $5.08B | $2.77B | $9.46B | $3.41B | $2.86B |
| Operating income | −$10.39B | $2.69B | $2.99B | $3.33B | $2.47B | $2.24B | $2.45B | $888.0M | $2.64B | −$4.32B | $1.61B | $2.62B |
| Interest income | $45.0M | $95.0M | $95.0M | $88.0M | $73.0M | $94.0M | $85.0M | $52.0M | $35.0M | $108.0M | — | $106.0M |
| Interest expense | $247.0M | $240.0M | $255.0M | $256.0M | $254.0M | $260.0M | $249.0M | $238.0M | $237.0M | $254.0M | $252.0M | $232.0M |
| Income before taxes | −$10.25B | $2.58B | $2.08B | $3.64B | $2.43B | $1.65B | $2.17B | $956.0M | $2.05B | −$4.49B | $1.65B | $2.32B |
| Income taxes | $242.0M | $559.0M | −$105.0M | $589.0M | $468.0M | $334.0M | $385.0M | −$297.0M | $438.0M | −$315.0M | $237.0M | $146.0M |
| Net income | −$10.50B | $2.02B | $2.18B | $3.05B | $1.96B | $1.31B | $1.78B | $1.25B | $1.61B | −$4.17B | $1.43B | $2.18B |
| EBITDA | −$9.31B | $3.51B | $3.02B | $4.58B | $3.37B | $2.60B | $3.11B | $1.88B | $2.98B | −$3.54B | $2.59B | $3.23B |
| EPS (diluted) | −$6.75 | $2.03 | $1.86 | $2.47 | $2.01 | $1.81 | $1.90 | $2.02 | $2.01 | −$1.32 | $1.72 | $2.29 |
| Gross margin | 79.8% | 79.2% | 79.5% | 79.8% | 78.8% | 76.9% | 79.1% | 79.1% | 77.8% | 76.8% | 70.6% | 77.8% |
| Operating margin | −133.2% | 38.7% | 37.7% | 42.8% | 34.9% | 33.6% | 32.4% | 11.8% | 38.0% | −64.6% | 22.7% | 37.2% |
| Net margin | −134.5% | 29.0% | 27.5% | 39.3% | 27.7% | 19.7% | 23.6% | 16.6% | 23.2% | −62.4% | 20.1% | 30.9% |
Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported in GILD's financial statements (latest annual report filed February 24, 2026); data from EODHD. Sales, general & administrative expenses include sales and marketing.
GILD financial results
In fiscal year 2025 (ended December 31, 2025), Gilead reported revenue of $29.4 billion, up 2.4% from the year before. It had net income of $8.5 billion (up 1,672.9%), a net profit margin of 28.9%. Diluted earnings per share came to $8.15. Over five years revenue grew at an average rate of 3.6% a year.
See the GILD stock overview for the latest quote and news, or the GILD chart for price history and technical indicators.
GILD income statement FAQ
What is Gilead's annual revenue?
Gilead reported total revenue of $29.4 billion for fiscal year 2025, which ended on December 31, 2025. That was up 2.4% from $28.8 billion the previous year.
Is Gilead profitable?
Yes. Gilead reported net income of $8.5 billion in fiscal 2025, a net profit margin of 28.9%; its operating margin was 39.7%.
What is Gilead's gross margin?
Gilead's gross margin was 78.8% in fiscal 2025: for every $100 of revenue, Gilead kept $79 after the direct cost of its products and services.
How much does Gilead spend on research and development?
Gilead spent $5.8 billion on research and development in fiscal 2025, 19.7% of revenue.
How fast is Gilead growing?
Revenue grew 3.6% a year on average over the last five fiscal years, from $24.7 billion to $29.4 billion.
What are Gilead's earnings per share?
Gilead earned $8.15 per diluted share in fiscal 2025, compared with $4.61 a year earlier.
When will Gilead report its next earnings?
Gilead is expected to report results for the quarter ending September 30, 2026 on October 29, 2026 after the market closes.
When does Gilead's fiscal year end?
Gilead's fiscal year ends in December. The latest annual report covers the year ended December 31, 2025 and was filed on February 24, 2026.